Sin Gon Kim, MD
Korea University Anam Hospital · KOREA University Anam Hospital, Seoul, South Korea
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sin Gon Kim, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:45 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07359105 · Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)Sin Gon Kim · recruiting · Dyslipidemia Associated With Type II Diabetes Mellitus · principal investigator
- Ph2NCT06712615 · Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 DiabetesProGen. Co., Ltd. · active not recruiting · Type 2 Diabetes Mellitus (T2DM), Obesity Type 2 Diabetes Mellitus · principal investigator
- Ph4NCT02512523 · Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)Handok Inc. · completed · Type 2 Diabetes Mellitus · principal investigator
- Ph4NCT00573950 · Effects of Cilostazol on Plasma Adipocytokine and Arterial StiffnessKorea University Anam Hospital · unknown · Diabetes Mellitus, Type 2, Metabolic Syndrome X · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.